Insmed(STG) IM8N

Market Cap€18.97B

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€84.90

-2.97%

-2.60Today

Insmed Financials at a Glance

Market Cap

€18.97B

Revenue (TTM)

€704.78

Net Income (TTM)

-€1.02K

EPS (TTM)

-€4.96

P/E Ratio

-17.63

Dividend

€0.00

Beta (Volatility)

0.07 (Low)

Dividend

€0.00

Beta (Volatility)

0.07 (Low)

Price

€84.90

Volume

200

Open

€88.81

Price

€84.90

Volume

200

Open

€88.81

Previous Close

€87.50

Daily Range

€84.38 - €89.17

52-Week Range

€78.79 - €184.00

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

0.07 (Low)

Price

€84.90

Volume

200

Open

€88.81

Previous Close

€87.50

Daily Range

€84.38 - €89.17

52-Week Range

€78.79 - €184.00

Estimated Earnings Date

N/A

IM8N News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Insmed

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Industry

Biotechnology

Sector

Health Care

Employees

1,664

CEO

Will Lewis, MBA

Website

www.insmed.com

IM8N Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-290.66%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-5.67%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€18.97B

Shares Outstanding

216.75M

Volume

200

Avg. Volume

301

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Insmed Performance Analysis

Insmed annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 233,457,656	46.4%
2023	2023-12-31	EUR 282,308,385	20.9%
2024	2024-12-31	EUR 336,239,353	19.1%
2025	2025-12-31	EUR 537,333,730	59.8%

Insmed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -3.72	13.5%
2023	2023-12-31	EUR -4.94	32.6%
2024	2024-12-31	EUR -5.15	4.3%
2025	2025-12-31	EUR -5.68	10.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

€261.52

+3.0%

Gross Profit

€219.21

+3.3%

Gross Margin

83.82%

+1.1%

Market Cap

€18.97B

N/A

Market Cap/Employee

€18.14

N/A

Employees

1,664

N/A

Net Income

-€139.81

+0.6%

EBITDA

-€166.32

+0.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

€1.15K

-27.2%

Total Debt

€649.57

+0.5%

Accounts Receivable

€154.97

+3.5%

Inventory

€115.35

+1.2%

Long Term Debt

€637.05

+0.5%

Short Term Debt

€12.52

+1.3%

Return on Assets

-58.92%

+0.9%

Return on Invested Capital

-59.35%

+1.2%

Free Cash Flow

-€193.36

+0.7%

Operating Cash Flow

-€190.39

+0.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,485.58+0.01%

^DJIDJI

^DJIDJI$52,526.13+0.01%

^IXICNASDAQ

^IXICNASDAQ$25,334.92+0.01%

BTCBitcoin

BTCBitcoin$63,012.00-0.03%

SPCXSPCX

SPCXSPCX$108.28-0.03%

AAPLAAPL

AAPLAAPL$301.72-0.10%

AMZNAMZN

AMZNAMZN$271.44+0.15%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AMZNAmazon

AMZNAmazon$271.49+0.15%

FCUVFocus Universal

FCUVFocus Universal$16.56+7.81%

AAPLApple

AAPLApple$301.92-0.09%

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares

MUUDirexion Shares ETF Trust - Direxion Daily Mu Bull 2x Shares$24.54-0.09%

INTCIntel

INTCIntel$92.75+0.02%

NVDANvidia

NVDANvidia$199.21+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$64.84+0.02%

Questions About IM8N

What is the current price of Insmed?

Insmed is trading at €84.90 per share.

What is the 52-week range for Insmed?

Over the past 52 weeks, Insmed has traded between €78.79 and €184.00.

How much debt does Insmed have?

As of the most recent reporting period, Insmed reported total debt of €649.57M.

How much cash does Insmed have on hand?

Insmed reported €505.28M in cash and cash equivalents in its most recent financial results.

What is Insmed’s dividend yield?

Insmed does not currently have a dividend yield.

Insmed(STG) IM8N

Insmed Financials at a Glance

IM8N News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Insmed

IM8N Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Insmed Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IM8N

What is the current price of Insmed?

What is the 52-week range for Insmed?

How much debt does Insmed have?

How much cash does Insmed have on hand?

What is Insmed’s dividend yield?

Premium Investing Services